SGLT2 Inhibitors Linked to Cardiorenal Benefits Across CKM Syndrome Stages 2–4
A large analysis of clinical-trial evidence suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the heart and kidneys across multiple ...
A large analysis of clinical-trial evidence suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the heart and kidneys across multiple ...
In an emerging field of geriatric medicine, researchers are increasingly focused on understanding the complex interplay between multiple chronic conditions ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine